AI in Healthcare: Developing a Targeted Strategy

1. AI in Healthcare: Developing a Targeted Strategy Our client’s medication has long been a staple in the U.S. market, widely known for its efficacy in pain relief and cardiovascular health. However, recent clinical research has impacted the brand’s market perception, with studies such as the A, B, and C trials examining the broader health implications of medication use, especially for cardiovascular health in low-dose regimens. The findings from these studies have prompted mixed responses from healthcare professionals (HCPs) and patients, affecting their inclination toward our client’s medication use in general. Our client has a tactical advantage in navigating the complexities of the medication industry due to its usage ofAI in healthcareto understand consumer and HCPs’ attitudes and preferences. Background The A trial reviewed medication’s effect on preventing cardiovascular events in diabetic patients but reported no significant advantage in primary prevention, leading to skepticism among HCPs. Similarly, the B trial, our client’s own research initiative, echoed caution by evaluating medication’s limited benefits in specific populations. Lastly, the C trial funded by NIH found no substantial improvement in life span with daily low-dose medication use in older adults. Consequently, this emerging data has shifted the perspectives of HCPs and patients alike, influencing Our client’s market positioning. AI in Healthcare: The Approach to Market Strategy Considering the shifting landscape, our client has recognized the need for a refined approach to understand and cater to HCP and patient sentiments. The proposed strategy leverages AI in healthcare to segment and analyze the attitudes of HCPs and patients

2. toward Our client’s medication, enabling targeted interventions. The primary goals of this AI- driven approach include identifying segments that have remained positive about Our client’s medication, converting those who have become skeptical, and gaining a nuanced understanding of the motivational factors and distinct characteristics of each group. AI in Healthcare: Key Findings and Data Analysis The analysis usingAI in healthcarereveals distinct groups based on their sentiments and prescribing behaviors: 1.Decline in Positive Sentiment oMany HCPs and patients who previously viewed our client’s medication favorably are showing a shift towards neutral or negative perspectives due to concerns around medication’s effectiveness in primary prevention, as highlighted by recent studies. oPatients are more sensitive to these findings than HCPs, showing a marked decline in positivity. This change is also influenced by factors such as cost and perceived benefits compared to generic medication alternatives. 2.Comparison with Generic Medication oSome patients and HCPs have increasingly opted for generic medication due to its affordability and similar efficacy profile. HCPs who remained positive about medication often expressed preferences for generics, citing cost- efficiency and consistent patient outcomes. 3.Distinct Profiles of Positive vs. Negative Segments oFor those remaining positive toward our client’s medication, preferences often stem from long-term usage and established patient-doctor trust. Many of these users appreciate our client’s unique features, such as coated or enteric- coated options, which are perceived as gentler on the stomach. oNegative perspectives are often found in individuals skeptical about medication’s primary prevention efficacy. Common reasons include the cost of branded medication and doubts over added benefits from Our client’s coating or other features. oThese profiles show a trend where the perceived benefit of Our client’s coating or branding may not justify the cost for many patients, particularly when generics are available at a lower price. Some additional findings are not disclosed due to the interest of confidentiality. Strategic Steps to Regain and Retain Positive Sentiment With insights derived from the data analysis usingAI in healthcare, our client’s approach to addressing HCP and patient perspectives can be tailored in specific ways to enhance engagement, improve brand loyalty, and educate the market on the unique benefits of Our client’s medication: 1.Segmented and Unbiased Targeting Using AI oBy segmenting both HCPs and patients based on inclination, our client can better understand drivers of positivity and negativity. This approach will inform

3. efforts to increase the base of loyal HCPs and patients while addressing the concerns of those who have turned skeptical. oFor example, targeting the specific profiles that remained positive with tailored messaging around the benefits of Our client’s formulations, such as enteric coating, may reinforce brand loyalty. 2.Deep Dive Analysis for Insightful Messaging oEach segment’s unique characteristics—such as age, clinic size, fitness priorities, health concerns and media consumption —inform tailored strategies for messaging. Younger HCPs and those operating in smaller clinics may have different informational needs than established doctors in larger facilities. oPatients with health-conscious profiles, like those worried about fitness or who have a higher BMI, might benefit from educational content that clarifies the protective role of medication in specific contexts, alongside lifestyle recommendations that align with medication use. 3.Educational Initiatives on Recent Research and Medication Use oAddressing the confusion resulting from clinical trials such as A, B, and C, our client could develop educational content that clarifies when medication use is most beneficial, backed by clear, evidence-based explanations that speak to both HCPs and patients. oInteractive webinars, seminars, and targeted digital campaigns can reinforce Our client’s commitment to transparent communication and educate HCPs on the specific scenarios where medication can provide health benefits without undue risk. 4.Emphasis on Unique Product Benefits oWhile generics remain attractive for cost-conscious patients, our client can differentiate its product through an emphasis on features like enteric coating, known to reduce gastrointestinal side effects, which can be a persuasive point for patients and HCPs prioritizing gastrointestinal health. oBy aligning this messaging with targeted marketing toward individuals who may benefit from these product features, our client can reestablish the brand’s premium positioning, focusing on quality and patient-centered care. Strategize Better with AI in Healthcare The application of AI in healthcare to understand the sentiments and preferences of HCPs and patients provides our clients with a strategic advantage in navigating the complexities of the medication market. The study was conducted along with trials that were run to get a time advantage in driving actions faster than competitors. Through informed and nuanced AI- driven strategies, our client is positioned to reinforce its market presence, enhance brand loyalty, and sustain its role as a trusted provider of medication in the U.S . Contact usat GrapheneAI to enhance your market position with AI in healthcare. Also, read about the othercase studywhere our client was able to regain and retain positive sentiment.